UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 163

Sortiert nach

Pretreatment lactate dehydrogenase may predict outcome of advanced non small‐cell lung cancer patients treated with immune checkpoint inhibitors: A meta‐analysis

Cancer medicine (Malden, MA), 2019-04, Vol.8 (4), p.1467-1473

2019

Volltextzugriff (PDF)

Systematic assessment of the clinicopathological prognostic significance of tissue cytokine expression for lung adenocarcinoma based on integrative analysis of TCGA data

Scientific reports, 2019-04, Vol.9 (1), p.6301-6301, Article 6301

2019

Volltextzugriff (PDF)

Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) May Predict the Outcomes of Advanced Non-small-cell Lung Cancer (NSCLC) Patients Treated With Immune Checkpoint Inhibitors (ICIs)

Frontiers in oncology, 2020-06, Vol.10, p.654-654

2020

Volltextzugriff (PDF)

Methylation of NRN1 is a novel synthetic lethal marker of PI3K‐Akt‐mTOR and ATR inhibitors in esophageal cancer

Cancer science, 2021-07, Vol.112 (7), p.2870-2883

2021

Volltextzugriff (PDF)

Ascites-derived IL-6 and IL-10 synergistically expand CD14 + HLA-DR -/low myeloid-derived suppressor cells in ovarian cancer patients

Oncotarget, 2017-09, Vol.8 (44), p.76843-76856

2017

Volltextzugriff (PDF)

Neratinib, an Irreversible ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced ErbB2-Positive Breast Cancer

Journal of clinical oncology, 2010-03, Vol.28 (8), p.1301-1307

2010

Volltextzugriff (PDF)

Checkpoint blockade‐based immunotherapy in the context of tumor microenvironment: Opportunities and challenges

Cancer medicine (Malden, MA), 2018-09, Vol.7 (9), p.4517-4529

2018

Volltextzugriff (PDF)

Nomogram for predicting survival in patients with advanced hepatocellular carcinoma treated with PD-1 inhibitors: incorporating pre-treatment and post-treatment clinical parameters

BMC cancer, 2023-06, Vol.23 (1), p.556-556, Article 556

2023

Volltextzugriff (PDF)

Clinical Activity and Safety of Penpulimab (Anti-PD-1) With Anlotinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: An Open-Label, Multicenter, Phase Ib/II Trial (AK105-203)

Frontiers in oncology, 2021-07, Vol.11, p.684867-684867

2021

Volltextzugriff (PDF)

TP53 R273C Mutation Is Associated With Poor Prognosis in LGG Patients

Frontiers in genetics, 2022-03, Vol.13, p.720651-720651

2022

Volltextzugriff (PDF)

CXCL10 and IL15 co-expressing chimeric antigen receptor T cells enhance anti-tumor effects in gastric cancer by increasing cytotoxic effector cell accumulation and survival

Oncoimmunology, 2024-12, Vol.13 (1), p.2358590-2358590

2024

Volltextzugriff (PDF)

Tetramethylpyrazine inhibits tumor growth of lung cancer through disrupting angiogenesis via BMP/Smad/Id-1 signaling

International journal of oncology, 2016-05, Vol.48 (5), p.2079-2086

2016

Volltextzugriff (PDF)

The role of miR-485-5p/NUDT1 axis in gastric cancer

Cancer cell international, 2017-10, Vol.17 (1), p.92-92, Article 92

2017

Volltextzugriff (PDF)

Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2016-01, Vol.19 (1), p.234-244

2016

Volltextzugriff (PDF)

A signature motif in LIM proteins mediates binding to checkpoint proteins and increases tumour radiosensitivity

Nature communications, 2017-01, Vol.8 (1), p.14059-14059, Article 14059

2017

Volltextzugriff (PDF)

A nomogram-based immunoprofile predicts overall survival for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy

Journal for immunotherapy of cancer, 2018-10, Vol.6 (1), p.100-100, Article 100

2018

Volltextzugriff (PDF)

Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation

Frontiers in pharmacology, 2022-11, Vol.13, p.993022

2022

Volltextzugriff (PDF)

Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer

Cancer medicine (Malden, MA), 2019-08, Vol.8 (10), p.4699-4708

2019

Volltextzugriff (PDF)

Genomic profiling of Chinese patients with urothelial carcinoma

BMC cancer, 2021-02, Vol.21 (1), p.162-162, Article 162

2021

Volltextzugriff (PDF)

miR-409 Inhibits Human Non-Small-Cell Lung Cancer Progression by Directly Targeting SPIN1

Molecular therapy. Nucleic acids, 2018-12, Vol.13, p.154-163

2018

Volltextzugriff (PDF)

HIF-1 alpha overexpression correlates with poor overall survival and disease-free survival in gastric cancer patients post-gastrectomy

PloS one, 2014-03, Vol.9 (3), p.e90678-e90678

2014

Volltextzugriff (PDF)

Diversity of Dominant Peripheral T Cell Receptor Clone and Soluble Immune Checkpoint Proteins Associated With Clinical Outcomes Following Immune Checkpoint Inhibitor Treatment in Advanced Cancers

Frontiers in immunology, 2021-06, Vol.12, p.649343

2021

Volltextzugriff (PDF)

Predictive Biomarkers of Dicycloplatin Resistance or Susceptibility in Prostate Cancer

Frontiers in genetics, 2021-07, Vol.12, p.669605-669605

2021

Volltextzugriff (PDF)

Corrigendum: Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation

Frontiers in pharmacology, 2023, Vol.14, p.1140018-1140018

2023

Volltextzugriff (PDF)

1 – 25 von 163

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(131)
Mit Volltextzugriff
(142)

Publikationsform

Artikel
(160)
Berichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pretreatment lactate dehydrogenase may predict outcome of advanced non small‐cell lung cancer patients treated with immune checkpoint inhibitors: A meta‐analysis

Systematic assessment of the clinicopathological prognostic significance of tissue cytokine expression for lung adenocarcinoma based on integrative analysis of TCGA data

Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) May Predict the Outcomes of Advanced Non-small-cell Lung Cancer (NSCLC) Patients Treated With Immune Checkpoint Inhibitors (ICIs)

Methylation of NRN1 is a novel synthetic lethal marker of PI3K‐Akt‐mTOR and ATR inhibitors in esophageal cancer

Ascites-derived IL-6 and IL-10 synergistically expand CD14 + HLA-DR -/low myeloid-derived suppressor cells in ovarian cancer patients

Neratinib, an Irreversible ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced ErbB2-Positive Breast Cancer

Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial

Checkpoint blockade‐based immunotherapy in the context of tumor microenvironment: Opportunities and challenges

Nomogram for predicting survival in patients with advanced hepatocellular carcinoma treated with PD-1 inhibitors: incorporating pre-treatment and post-treatment clinical parameters

Clinical Activity and Safety of Penpulimab (Anti-PD-1) With Anlotinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: An Open-Label, Multicenter, Phase Ib/II Trial (AK105-203)

TP53 R273C Mutation Is Associated With Poor Prognosis in LGG Patients

CXCL10 and IL15 co-expressing chimeric antigen receptor T cells enhance anti-tumor effects in gastric cancer by increasing cytotoxic effector cell accumulation and survival

Tetramethylpyrazine inhibits tumor growth of lung cancer through disrupting angiogenesis via BMP/Smad/Id-1 signaling

The role of miR-485-5p/NUDT1 axis in gastric cancer

Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer

A signature motif in LIM proteins mediates binding to checkpoint proteins and increases tumour radiosensitivity

A nomogram-based immunoprofile predicts overall survival for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy

Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation

Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer

Genomic profiling of Chinese patients with urothelial carcinoma

miR-409 Inhibits Human Non-Small-Cell Lung Cancer Progression by Directly Targeting SPIN1

HIF-1 alpha overexpression correlates with poor overall survival and disease-free survival in gastric cancer patients post-gastrectomy

Diversity of Dominant Peripheral T Cell Receptor Clone and Soluble Immune Checkpoint Proteins Associated With Clinical Outcomes Following Immune Checkpoint Inhibitor Treatment in Advanced Cancers

Predictive Biomarkers of Dicycloplatin Resistance or Susceptibility in Prostate Cancer

Corrigendum: Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation

Suchergebnisse filtern